The study, conducted by a team of doctors at Biel Hospital Centre and published on Monday, analysed photos of shop windows from 68 randomly selected pharmacies in Switzerland. The team found that of the 970 medicines examined, only 418 (or 43.1%) had proven efficacy.
The data on the remaining 556 medicines (or 56.9%) are too thin to draw any reliable conclusions about their effectiveness.
These results can be explained in part by the fact that pharmacies are not allowed to advertise prescription medicines like antibiotics in their windows, notes the study published in the British Medical Journal Open.
“Most of them are homeopathic medicines that have never proved effective in any study. So you can drink gallons of them and you’ll probably have neither primary effects nor side effects,” explained Professor Daniel Genné, who directed the study.
But he told Swiss public broadcaster RTS that this proportion is still problematic. “These are still surprising results, which could also have consequences for patients,” he said.
While the drugs on display are not dangerous to health, Genné points out that they are sold to people with symptoms. “It could just be anxiety, but it could also be a serious illness for which effective treatment needs to be given. So it could delay a diagnosis.”
Genné’s team regrets the presence of so many drugs with no proven efficacy in shop windows. By giving them this visibility, pharmacies are indirectly recommending them to the public, who are increasingly resorting to self-medication. However, some patients are unaware that non-prescription drugs can interact with other medicines.
The researchers are therefore proposing to introduce a label on all non-prescription medicines indicating their level of efficacy, “just as electrical appliances have been classified from A to F according to their level of energy efficiency”. This would enable patients to make informed decisions about the medicines they choose to buy.
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Swiss Abroad
An eye-opening guide to Switzerland’s ear-splitting sirens
Number of bearded vultures in the Alps could double in ten years
This content was published on
The bearded vultures in the Alps are currently doing so well that their population could double to around 700 animals within ten years.
Hardly any violations of minimum wage regulations in Ticino
This content was published on
A good 3% of companies inspected have violated the minimum wage in the Swiss canton of Ticino in the past three years, according to an official review.
Mandatory EU referendum not possible, says Swiss commission
This content was published on
Switzerland's treaties with the European Union cannot be subject to a mandatory referendum. This is the opinion of the majority of the responsible committee of the House of Representatives.
Consumer group files legal complaint against Swiss shoemaker On
This content was published on
The consumer affairs bureau of French-speaking Switzerland has filed a legal complaint against On accusing it of greenwashing.
This content was published on
Thomas Schinecker, CEO of Swiss pharma firm Roche, has dismissed fears that sales targets would be under threat by US tariffs.
This content was published on
Researchers are asking the Swiss public for help in naming two newly discovered Swiss fish species of the genus Barbatula.
Science alliance warns against Swiss government’s cost-cutting plans
This content was published on
An alliance of research and science institutions have warned of dire consequences if the Swiss government goes ahead with its austerity package.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss government to save CHF250 million with generic drug promotion
This content was published on
Generic drugs will become cheaper than original drugs and patients’ co-payment will increase if they choose the more expensive product.
Swiss cities test controlled cannabis distribution
This content was published on
Swiss drug policy is shifting. Some pharmacies and social clubs in major cities are making cannabis available for recreational purposes.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.